Position in NVS
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$242,289
+$6,138 QoQ
Shares Held
1,546
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.13%
of 13F equity value
Holder Rank
#1,231
of 1,603 holders
Holding Since
Dec 2021
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Tevis Investment Management holds $14,056,408 across 7 Drug Manufacturers - General names. NVS ranks #7 (1.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
21,418 | $5,439,529 | |
| 2 | NVO |
Novo Nordisk A S
|
75,115 | $3,601,013 | |
| 3 | LLY |
ELI LILLY & Co
|
1,932 | $2,317,298 | |
| 4 | ABBV |
AbbVie Inc.
|
4,000 | $1,006,560 | |
| 5 | MRK |
Merck & Co., Inc.
|
7,534 | $968,119 | |
| 6 | PFE |
Pfizer Inc
|
20,000 | $481,600 | |
| 7 | NVS |
Novartis AG
This page
|
1,546 | $242,289 |
All Filings in NVS
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $242,289 | 1,546 | Shares | Sole | 2026-08-06 | |
| 2026-03-31 | $236,151 | 1,546 | Shares | Sole | 2026-05-04 | |
| 2022-09-30 | $105,729 | 1,391 | Shares | Sole | 2022-11-07 | |
| 2022-06-30 | $117,579 | 1,391 | Shares | Sole | 2022-08-08 | |
| 2022-03-31 | $122,059 | 1,391 | Shares | Sole | 2022-08-05 | |
| 2021-12-31 | $121,669 | 1,391 | Shares | Sole | 2022-08-05 | |
| No filing history on record for this holder in this stock. | ||||||